IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q3 2022 Holdings

Filed 2022-10-05 | 8 holdings | $19.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$19.4M1,798,16399.5%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$28.2K2,220,0340.1%
Kinnate Biopharma, Inc.Common Stock49705R105$26.4K2,207,7720.1%
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$15.8K3,931,8180.1%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$9.3K2,765,3140.0%
Praxis Precision Medicines, Inc.Common Stock74006W108$6.7K2,939,3290.0%
LianBioOrdinary Shares53000N108$4.6K2,282,0840.0%
Homology Medicines, Inc.Common Stock438083107$1.1K696,2890.0%